Seto Hiroyuki, Nishimura Mitsushige, Minamiji Katsuhiro, Miyoshi Sonoko, Mori Hiroyuki, Kanazawa Kenji, Yasuda Hisafumi
Department of General Internal Medicine, Kobe University Hospital, Japan.
Intern Med. 2016;55(22):3383-3386. doi: 10.2169/internalmedicine.55.7255. Epub 2016 Nov 15.
We herein report the case of a 63-year-old man who presented with a 3-month history of a cutaneous nodular lesion of his jaw, low grade fever, lethargy and progressive cognitive impairment. He had a 30-year history of multiple sclerosis and had been treated with fingolimod for the previous 2 years. Laboratory data revealed CD4 lymphocytopenia and a tissue culture of the skin nodule was positive for Cryptococcus neoformans. Cerebrospinal fluid and serum cryptococcal antigen tests were also positive and we diagnosed him to have disseminated cryptococcosis. This dissemination might be associated with fingolimod-induced CD4 lymphocytopenia. The risk of an opportunistic infection should therefore be considered when encountering fingolimod-treated patients.
我们在此报告一例63岁男性患者,其颌部出现皮肤结节性病变3个月,伴有低热、乏力和进行性认知障碍。他有30年的多发性硬化病史,此前2年一直使用芬戈莫德治疗。实验室检查显示CD4淋巴细胞减少,皮肤结节的组织培养新型隐球菌呈阳性。脑脊液和血清隐球菌抗原检测也呈阳性,我们诊断他患有播散性隐球菌病。这种播散可能与芬戈莫德诱导的CD4淋巴细胞减少有关。因此,在遇到接受芬戈莫德治疗的患者时,应考虑机会性感染的风险。